Dow Jones

38 798,99

-0,22%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Neurochem - Common Shares (MM) (NRMX)
Neurochem - Common Shares (MM) (NRMX) Actualités

NRMX

Neurochem (NRMX)

Neurochem - Common Shares (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:NRMX

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
16/04/2008	17h57	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
15/04/2008	14h00	PR Newswire (US)	At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update o	NASDAQ:NRMX
11/04/2008	20h30	PR Newswire (US)	Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008	NASDAQ:NRMX
11/04/2008	18h24	PR Newswire (US)	Neurochem Annual and Special Meeting of shareholders	NASDAQ:NRMX
10/04/2008	17h26	Edgar (US Regulatory)	Neurochem Inc - Amended Annual Report (foreign private issuer) (40-F/A)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
14/03/2008	22h07	Edgar (US Regulatory)	Neurochem Inc - Annual Report (foreign private issuer) (40-F)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
13/03/2008	12h00	PR Newswire (US)	Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis	NASDAQ:NRMX
22/02/2008	01h19	PR Newswire (US)	Neurochem announces departure of two members of management team	NASDAQ:NRMX
21/02/2008	22h54	Edgar (US Regulatory)	Neurochem Inc - Amended Report of Foreign Issuer (6-K/A)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
21/02/2008	01h12	PR Newswire (US)	Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives	NASDAQ:NRMX
13/02/2008	18h26	PR Newswire (US)	/C O R R E C T I O N from source -- Neurochem Inc./	NASDAQ:NRMX
11/02/2008	16h46	PR Newswire (US)	Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live	NASDAQ:NRMX
30/01/2008	14h00	PR Newswire (US)	Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business	NASDAQ:NRMX
03/01/2008	19h08	PR Newswire (US)	Neurochem to present at JPMorgan Healthcare Conference	NASDAQ:NRMX
14/12/2007	14h24	PR Newswire (US)	Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis	NASDAQ:NRMX
06/12/2007	23h09	PR Newswire (US)	Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review	NASDAQ:NRMX
30/11/2007	22h15	PR Newswire (US)	Neurochem announces departure of Dr. Philippe Calais, President, Global Business	NASDAQ:NRMX
08/11/2007	13h00	PR Newswire (US)	Neurochem announces important initiatives to provide medical and health benefits to patients	NASDAQ:NRMX	Neurochem - Common Shares (MM)
08/11/2007	00h55	PR Newswire (US)	Neurochem reports results for third quarter of fiscal 2007	NASDAQ:NRMX
28/08/2007	19h20	PR Newswire (US)	Neurochem provides information on cash position	NASDAQ:NRMX
27/08/2007	02h02	PR Newswire (US)	Neurochem Announces results from Tramiprosate (ALZHEMED(TM)) North American Phase III Clinical Trial	NASDAQ:NRMX
09/08/2007	23h05	PR Newswire (US)	Neurochem reports results for second quarter of fiscal 2007	NASDAQ:NRMX
24/07/2007	13h00	PR Newswire (US)	Neurochem granted Fast Track designation from U.S. FDA for tramiprosate (ALZHEMED(TM))	NASDAQ:NRMX
17/07/2007	21h57	PR Newswire (US)	Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis	NASDAQ:NRMX
26/06/2007	19h10	PR Newswire (US)	Neurochem to present at Jefferies Healthcare Conference	NASDAQ:NRMX
22/06/2007	22h29	PR Newswire (US)	Tramiprosate (ALZHEMED(TM)) North American Phase III clinical trial progress update	NASDAQ:NRMX
21/06/2007	14h00	PR Newswire (US)	Neurochem receives third recommendation from European Data Safety Monitoring Board to continue Phase III clinical trial for tram	NASDAQ:NRMX
18/06/2007	14h00	PR Newswire (US)	Neurochem Announces Mandatory and Full Conversion of All Oustanding Senior Subordinated Convertible Notes	NASDAQ:NRMX	Neurochem - Common Shares (MM)
11/06/2007	12h55	PR Newswire (US)	At the 2007 Alzheimer's Association International Conference on the Prevention of Dementia - Neurochem's U.S. Principal Investig	NASDAQ:NRMX
07/06/2007	14h00	PR Newswire (US)	Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA(TM)) Treatment fo	NASDAQ:NRMX